Vitamin D, drug metabolism, and cardiovascular complications in pediatric HIV
儿科 HIV 患者的维生素 D、药物代谢和心血管并发症
基本信息
- 批准号:8898162
- 负责人:
- 金额:$ 32.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:25-hydroxyvitamin DAIDS preventionAdultAffinityAtherosclerosisCardiacCardiovascular DiseasesCardiovascular systemChildChildhoodCholecalciferolComorbidityControl GroupsCross-Sectional StudiesDataDevelopmentDiabetes MellitusDoseDyslipidemiasEffectivenessGeneral PopulationHIVHIV therapyHeart DiseasesHigh PrevalenceHyperglycemiaHypertensionImmuneInflammationInsulin ResistanceInterventionIntervention StudiesLifeLinkLipoproteinsMeasuresMediatingMetabolicMetabolic syndromeMetabolismMorbidity - disease rateObesityObservational StudyPathway interactionsPatientsPilot ProjectsPopulationPrevalenceRandomizedReportingRiskRisk FactorsSerumSupplementationSurrogate MarkersToxic effectVitamin DVitamin D DeficiencyVitamin D-Binding Proteinantiretroviral therapycardiovascular disorder riskcardiovascular risk factorclinical practiceclinically significantdrug metabolismefavirenzheart disease riskimprovedinflammatory markerinsulin sensitivityintimal medial thickeningnon-nucleoside reverse transcriptase inhibitorspediatric human immunodeficiency virusurinaryyoung adult
项目摘要
DESCRIPTION (provided by applicant): Vitamin D functions as a powerful immune modulator and its insufficiency has recently emerged as a risk factor for cardiovascular disease (CVD) and insulin resistance in the general population. Recently, the prevalence of vitamin D insufficiency and deficiency was recognized to be very high in the US pediatric population and low serum vitamin D were found to be strongly and independently associated with hypertension, hyperglycemia, and metabolic syndrome, independent of adiposity or other CVD risk factors. As HIV-infected children are expected to live several decades, issues of long- term toxicities, such as CVD and diabetes become increasingly important in the management of HIV. The central hypothesis of our proposed studies is that, vitamin D deficiency is a risk factor for the development of subclinical atherosclerosis and insulin resistance in HIV infected children/young adults, and that the risk is mediated by changes in systemic inflammation. To strengthen the findings from the observational study, we will conduct an interventional study, in which we hypothesize that high doses of vitamin D given to HIV-infected children/young adults with low vitamin D levels will increase 25-hydroxyvitamin D (25(OH)D) levels at a lower extent than in a matched healthy HIV-negative control group, specifically in patients treated with NNRTI, and will reduce inflammation, insulin resistance and dyslipidemias. Detailed measures of vitamin D pathways will also be determined. The use of vitamin D has the potential to have a significant impact on prevention of HIV cardiovascular and metabolic co-morbidities especially given that the intervention can be implemented easily and inexpensively in clinical practice.
描述(由申请人提供):维生素D作为一种强大的免疫调节剂,其不足最近被认为是普通人群心血管疾病(CVD)和胰岛素抵抗的危险因素。最近,维生素D不足和缺乏的患病率在美国儿科人群中被认为非常高,血清维生素D水平低被发现与高血压、高血糖和代谢综合征有很强的独立相关性,与肥胖或其他心血管疾病危险因素无关。由于感染艾滋病毒的儿童预计可以活几十年,长期毒性问题,如心血管疾病和糖尿病,在艾滋病毒的管理中变得越来越重要。我们提出的研究的中心假设是,维生素D缺乏是艾滋病毒感染儿童/年轻人发生亚临床动脉粥样硬化和胰岛素抵抗的危险因素,并且这种风险是由全身炎症变化介导的。为了加强观察性研究的发现,我们将进行一项干预性研究,在该研究中,我们假设高剂量的维生素D给予低维生素D水平的hiv感染儿童/年轻人,会比匹配的健康hiv阴性对照组增加25(OH)D (25(OH)D)水平,特别是在接受NNRTI治疗的患者中,并会减少炎症、胰岛素抵抗和血脂异常。还将确定维生素D途径的详细测量方法。维生素D的使用有可能对预防艾滋病毒心血管和代谢合并症产生重大影响,特别是考虑到在临床实践中可以很容易和廉价地实施干预。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Risk factors for vitamin D deficiency and relationship with cardiac biomarkers, inflammation and immune restoration in HIV-infected youth.
- DOI:10.3851/imp2318
- 发表时间:2012
- 期刊:
- 影响因子:1.2
- 作者:Eckard AR;Judd SE;Ziegler TR;Camacho-Gonzalez AF;Fitzpatrick AM;Hadley GR;Grossmann RE;Seaton L;Seydafkan S;Mulligan MJ;Rimann N;Tangpricha V;McComsey GA
- 通讯作者:McComsey GA
Long-term changes in carotid intima-media thickness among HIV-infected children and young adults.
- DOI:10.3851/imp2678
- 发表时间:2014
- 期刊:
- 影响因子:1.2
- 作者:Ross Eckard A;O'Riordan MA;Storer N;McComsey GA
- 通讯作者:McComsey GA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GRACE A MCCOMSEY其他文献
GRACE A MCCOMSEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GRACE A MCCOMSEY', 18)}}的其他基金
Clinical and Translational Science Collaborative of Northern Ohio, Catalyzing Linkages to Equity in Health (CLE Health)
北俄亥俄州临床和转化科学合作组织,促进健康公平的联系 (CLE Health)
- 批准号:
10704417 - 财政年份:2023
- 资助金额:
$ 32.32万 - 项目类别:
Clinical and Translational Science Collaborative of Cleveland
克利夫兰临床与转化科学合作组织
- 批准号:
10152707 - 财政年份:2018
- 资助金额:
$ 32.32万 - 项目类别:
Clinical and Translational Science Collaborative of Cleveland
克利夫兰临床与转化科学合作组织
- 批准号:
10400700 - 财政年份:2018
- 资助金额:
$ 32.32万 - 项目类别:
Incremental effect of smoking on HIV immune activation and cardiac health
吸烟对艾滋病毒免疫激活和心脏健康的增量影响
- 批准号:
8915891 - 财政年份:2014
- 资助金额:
$ 32.32万 - 项目类别:
Vitamin D, drug metabolism, and cardiovascular complications in pediatric HIV
儿科 HIV 患者的维生素 D、药物代谢和心血管并发症
- 批准号:
8196123 - 财政年份:2011
- 资助金额:
$ 32.32万 - 项目类别:
Vitamin D, drug metabolism, and cardiovascular complications in pediatric HIV
儿科 HIV 患者的维生素 D、药物代谢和心血管并发症
- 批准号:
8511762 - 财政年份:2011
- 资助金额:
$ 32.32万 - 项目类别:
相似海外基金
HIV/AIDS prevention and intervention: HIV surveillance methods, Per-exposure prophylaxis eligibility and HIV/STI testing behaviours among a cohort of people living with HIV.
HIV/艾滋病预防和干预:HIV 感染者群体中的 HIV 监测方法、每次暴露预防资格和 HIV/STI 检测行为。
- 批准号:
495195 - 财政年份:2023
- 资助金额:
$ 32.32万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10013921 - 财政年份:2020
- 资助金额:
$ 32.32万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10181081 - 财政年份:2020
- 资助金额:
$ 32.32万 - 项目类别:
UCLA AIDS Prevention and Treatment Clinical Trials Unit
加州大学洛杉矶分校艾滋病预防和治疗临床试验单位
- 批准号:
10166309 - 财政年份:2020
- 资助金额:
$ 32.32万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10597008 - 财政年份:2020
- 资助金额:
$ 32.32万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10386931 - 财政年份:2020
- 资助金额:
$ 32.32万 - 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
- 批准号:
9921510 - 财政年份:2019
- 资助金额:
$ 32.32万 - 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
- 批准号:
9753631 - 财政年份:2019
- 资助金额:
$ 32.32万 - 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
- 批准号:
10265667 - 财政年份:2019
- 资助金额:
$ 32.32万 - 项目类别:
Closing the Gap: Involving Indigenous Elders and youth in HIV/AIDS prevention using participatory filmmaking
缩小差距:利用参与式电影制作让土著老年人和青年参与艾滋病毒/艾滋病预防工作
- 批准号:
364681 - 财政年份:2017
- 资助金额:
$ 32.32万 - 项目类别:














{{item.name}}会员




